On the public citation graph

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis

https://doi.org/10.3390/cancers11101497
0 signed · 116 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/acn3.726openalex-snapshot
A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease
inferredcites →https://doi.org/10.1002/bmb.2003.494031050249openalex-snapshot
The urea cycle: Teaching intermediary metabolism in a physiological setting
inferredcites →https://doi.org/10.1002/hep.1840080310openalex-snapshot
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
inferredcites →https://doi.org/10.1002/hep.29086openalex-snapshot
AASLD guidelines for the treatment of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.29561openalex-snapshot
A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/mc.22967openalex-snapshot
Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2
inferredcites →https://doi.org/10.1007/s11306-019-1494-5openalex-snapshot
Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways
inferredcites →https://doi.org/10.1016/0005-2760(93)90161-2openalex-snapshot
Acylcarnitine formation and fatty acid oxidation in hepatocytes from rats treated with tetradecylthioacetic acid (a 3-thia fatty acid)
inferredcites →https://doi.org/10.1016/j.bbrc.2003.11.023openalex-snapshot
Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction
inferredcites →https://doi.org/10.1016/j.bbrc.2003.11.039openalex-snapshot
Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes
inferredcites →https://doi.org/10.1016/j.ejca.2011.12.021openalex-snapshot
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2017.01.009openalex-snapshot
High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation
inferredcites →https://doi.org/10.1016/j.jhep.2018.03.019openalex-snapshot
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/s0168-8278(00)80122-1openalex-snapshot
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma
inferredcites →https://doi.org/10.1038/nrendo.2014.171openalex-snapshot
Branched-chain amino acids in metabolic signalling and insulin resistance
inferredcites →https://doi.org/10.1038/nrm.2016.25openalex-snapshot
Metabolomics: beyond biomarkers and towards mechanisms
inferredcites →https://doi.org/10.1038/s41568-018-0054-zopenalex-snapshot
Rewiring urea cycle metabolism in cancer to support anabolism
inferredcites →https://doi.org/10.1038/s41598-018-30349-1openalex-snapshot
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
inferredcites →https://doi.org/10.1038/s41598-019-47216-2openalex-snapshot
Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2004.09.014openalex-snapshot
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
inferredcites →https://doi.org/10.1093/jnci/dji237openalex-snapshot
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
inferredcites →https://doi.org/10.1096/fj.03-1409fjeopenalex-snapshot
Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice
inferredcites →https://doi.org/10.1097/01.pai.0000213105.18569.faopenalex-snapshot
Geometry of Human Vascular System: Is it an Obstacle for Quantifying Antiangiogenic Therapies?
inferredcites →https://doi.org/10.1111/liv.12541openalex-snapshot
Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC / MS and UPLC / MS ‐ MS
inferredcites →https://doi.org/10.1126/science.aam9305openalex-snapshot
Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
inferredcites →https://doi.org/10.1146/annurev.nutr.22.110801.140547openalex-snapshot
R EGULATION OF E NZYMES OF THE U REA C YCLE AND A RGININE M ETABOLISM
inferredcites →https://doi.org/10.1186/s12986-018-0271-1openalex-snapshot
Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements
inferredcites →https://doi.org/10.1371/journal.pmed.1001624openalex-snapshot
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
inferredcites →https://doi.org/10.1371/journal.pmed.1002482openalex-snapshot
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
inferredcites →https://doi.org/10.1371/journal.pone.0127299openalex-snapshot
GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort
inferredcites →https://doi.org/10.21037/tgh.2018.07.06openalex-snapshot
Branched-chain amino acids in liver diseases
inferredcites →https://doi.org/10.2147/jhc.s159808openalex-snapshot
Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist
inferredcites →https://doi.org/10.2147/jhc.s61146openalex-snapshot
Hepatocellular carcinoma: a review
inferredcites →https://doi.org/10.3390/jpm8030028openalex-snapshot
A Metabolomics Approach to Pharmacotherapy Personalization
inferredcites →https://doi.org/10.3390/metabo9020036openalex-snapshot
Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3748/wjg.v19.i43.7620openalex-snapshot
Branched-chain amino acids in liver diseases
inferredcites →https://doi.org/10.3945/ajcn.2009.27462zopenalex-snapshot
Hepatic glutamate metabolism: a tale of 2 hepatocytes
inferredcites →https://doi.org/10.3978/j.issn.2304-3881.2014.07.06openalex-snapshot
Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?
inferredcites →https://doi.org/10.4254/wjh.v7.i2.139openalex-snapshot
Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4195311openalex-extracted
Integrated Network Pharmacology and Serum Metabolomics Analysis to Reveal the Mechanism of Gypenosides Against Lung Cancer and Enhancing Cisplatin Efficiency in Lewis Lung Cancer Mice
inferred← citeshttps://doi.org/10.1002/14651858.cd013346.pub2openalex-snapshot
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1007/978-1-0716-3694-7_14openalex-snapshot
Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-39094-4_4openalex-snapshot
Metabolomics Approach to Identify Biomarkers of Epidemic Diseases
inferred← citeshttps://doi.org/10.1007/s00216-025-05868-2openalex-snapshot
In-depth characterization of acylcarnitines: utilizing nitroxide radical–directed dissociation in tandem mass spectrometry
inferred← citeshttps://doi.org/10.1007/s00604-020-04504-3openalex-snapshot
Upconversion luminescence–infrared absorption nanoprobes for the detection of prostate-specific antigen
inferred← citeshttps://doi.org/10.1007/s11938-021-00347-wopenalex-snapshot
Metabolomics in Advanced Liver Disease
inferred← citeshttps://doi.org/10.1007/s12975-023-01137-5openalex-snapshot
Targeted Metabolomic Biomarkers for Stroke Subtyping
inferred← citeshttps://doi.org/10.1007/s13105-025-01119-1openalex-snapshot
Long non-coding RNA NR2F1-AS1: an increasingly significant LncRNA in human cancers
inferred← citeshttps://doi.org/10.1007/s13258-025-01655-6openalex-snapshot
Hierarchical structural component model for pathway analysis of multinomial phenotypes
inferred← citeshttps://doi.org/10.1007/s13258-026-01749-9openalex-snapshot
Parametric hypothesis testing for pathway based hierarchical structural component models
inferred← citeshttps://doi.org/10.1016/b978-0-323-85652-2.00014-2openalex-snapshot
Role of metabolomics to investigate combined effect of radiation and burn
inferred← citeshttps://doi.org/10.1016/j.bbcan.2020.188451openalex-snapshot
The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.cca.2024.117886openalex-snapshot
Metabolomics in cirrhosis: Recent advances and opportunities
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e23867openalex-snapshot
The role of serum acylcarnitine profiling for the detection of multiple solid tumors in humans
inferred← citeshttps://doi.org/10.1016/j.immuni.2019.11.012openalex-snapshot
Virus-Induced Interferon Regulates the Urea Cycle
inferred← citeshttps://doi.org/10.1016/j.jare.2024.09.007openalex-snapshot
Metabolic phenotyping combined with transcriptomics metadata fortifies the diagnosis of early-stage Hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.pdpdt.2022.103102openalex-snapshot
Urine fluorescence spectroscopy combined with machine learning for screening of hepatocellular carcinoma and liver cirrhosis
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106674openalex-snapshot
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
inferred← citeshttps://doi.org/10.1016/j.talanta.2023.125527openalex-snapshot
Comprehensive spectroscopic, metabolomic, and proteomic liquid biopsy in the diagnostics of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.trac.2025.118529openalex-snapshot
Lights and shadows of mass spectrometry-based metabolomics studies in cancer diagnosis: is there any marker beyond the literature background noise?
inferred← citeshttps://doi.org/10.1021/acs.analchem.2c03743openalex-snapshot
Multiscale Element-Doped Nanowire Array-Coupled Machine Learning Reveals Metabolic Fingerprints of Nonreversible Liver Diseases
inferred← citeshttps://doi.org/10.1021/acsomega.0c04259openalex-snapshot
LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis
inferred← citeshttps://doi.org/10.1038/s41598-020-59529-8openalex-snapshot
Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles
inferred← citeshttps://doi.org/10.1038/s41598-022-06614-9openalex-snapshot
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
inferred← citeshttps://doi.org/10.1038/s41598-023-28850-3openalex-snapshot
Metabolomic profiling in kidney cells treated with a sodium glucose-cotransporter 2 inhibitor
inferred← citeshttps://doi.org/10.1063/5.0116648openalex-snapshot
Microfluidic wearable electrochemical sweat sensors for health monitoring
inferred← citeshttps://doi.org/10.1080/09581596.2025.2608537openalex-snapshot
Comparative analysis of serum amino acid levels and their potential as biomarkers in liver cirrhosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1080/14737159.2024.2368603openalex-snapshot
Metabolomics for searching validated biomarkers in cancer studies: a decade in review
inferred← citeshttps://doi.org/10.1080/17501911.2024.2374702openalex-snapshot
Deciphering KDM8 dysregulation and CpG methylation in hepatocellular carcinoma using multi-omics and machine learning
inferred← citeshttps://doi.org/10.1093/bib/bbac171openalex-snapshot
DeepHisCoM: deep learning pathway analysis using hierarchical structural component models
inferred← citeshttps://doi.org/10.1093/bioinformatics/btac276openalex-snapshot
Kernel-based hierarchical structural component models for pathway analysis
inferred← citeshttps://doi.org/10.1097/md.0000000000028510openalex-snapshot
Metabolomic biomarkers for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/md.0000000000028820openalex-snapshot
A metabolomics strategy to identify potential biomarkers associated with human laryngeal cancer based on dried blood spot mass spectrometry approach
inferred← citeshttps://doi.org/10.1097/md.0000000000048540openalex-snapshot
Genetically predicted serum Pimelylcarnitine mediates the association between CD39+ secreting Treg cells and intervertebral disc degeneration
inferred← citeshttps://doi.org/10.1101/2021.02.16.431377openalex-snapshot
Anthracyclins increase free PUFAs and etherPEs with PUFAs as potential hallmarks of lipid peroxidation and ferroptosis
inferred← citeshttps://doi.org/10.1111/hepr.13506openalex-snapshot
Omics‐derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases
inferred← citeshttps://doi.org/10.1124/pharmrev.121.000408openalex-snapshot
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
inferred← citeshttps://doi.org/10.1155/2022/7840606openalex-snapshot
Circulating Metabolic Markers Related to the Diagnosis of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.11569/wcjd.v32.i8.561openalex-snapshot
Application of metabolomics in liver cirrhosis and its complications
inferred← citeshttps://doi.org/10.1186/s12864-024-09997-3openalex-snapshot
Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization study
inferred← citeshttps://doi.org/10.1186/s12876-023-02961-7openalex-snapshot
Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1186/s43066-026-00548-xopenalex-snapshot
Metabolic differences among patients with alcohol-related liver disease using targeted and untargeted metabolomics techniques
inferred← citeshttps://doi.org/10.18632/aging.102820openalex-snapshot
Development and validation of a prognostic classifier based on HIF-1 signaling for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.20892/j.issn.2095-3941.2020.0207openalex-snapshot
Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2801748/v1openalex-snapshot
Predictive value of serum amino acids as metabolite biomarkers in cirrhosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3372258/v1openalex-snapshot
Hepatocyte Growth Factor: A Potential Tumor Biomarker for Diagnosis of Fibrosis and Early Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.2147/ijgm.s334877openalex-snapshot
Integrated Analysis of miRNA and mRNA Expression Profiles Reveals the Molecular Mechanism of Posttraumatic Stress Disorder and Therapeutic Drugs
inferred← citeshttps://doi.org/10.2174/0929867330666230324153552openalex-snapshot
Metabolome Profiling of Malignant Ascites Identifies Candidate Metabolic Biomarkers of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.2174/2210298103666230410105139openalex-snapshot
Liquid Biopsy for Early Diagnosis of Hepatocellular Carcinoma: Current State and Future Perspectives
inferred← citeshttps://doi.org/10.3389/fcell.2022.960277openalex-snapshot
Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3389/fcimb.2021.725284openalex-snapshot
Specific Gut Microbiome and Serum Metabolome Changes in Lung Cancer Patients
inferred← citeshttps://doi.org/10.3389/fgene.2020.00857openalex-snapshot
Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1489077openalex-snapshot
Serum proteomic and metabolomic profiling of hepatocellular carcinoma patients co-infected with Clonorchis sinensis
inferred← citeshttps://doi.org/10.3389/fmed.2021.619077openalex-snapshot
Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD
inferred← citeshttps://doi.org/10.3389/fmed.2022.888850openalex-snapshot
The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective
inferred← citeshttps://doi.org/10.3389/fmedt.2022.1065506openalex-snapshot
Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
inferred← citeshttps://doi.org/10.3389/fmicb.2026.1927595openalex-snapshot
Etiology-associated differences in the gut microbiome and metabolome in hepatocellular carcinoma: an exploratory study of alcohol-related and HBV-related cases
inferred← citeshttps://doi.org/10.3389/fonc.2023.1123638openalex-snapshot
Focusing on discoidin domain receptors in premalignant and malignant liver diseases
inferred← citeshttps://doi.org/10.3389/fphar.2022.1070948openalex-snapshot
Comprehensive serum metabolomics and network analysis to reveal the mechanism of gypenosides in treating lung cancer and enhancing the pharmacological effects of cisplatin
inferred← citeshttps://doi.org/10.3390/cancers12092705openalex-snapshot
Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
inferred← citeshttps://doi.org/10.3390/cancers12113292openalex-snapshot
Cancer Alters the Metabolic Fingerprint of Extracellular Vesicles
inferred← citeshttps://doi.org/10.3390/cancers12123739openalex-snapshot
Human Hepatocellular Carcinoma (HCC)
inferred← citeshttps://doi.org/10.3390/cells10051163openalex-snapshot
Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
inferred← citeshttps://doi.org/10.3390/math12050725openalex-snapshot
Persistent Homology Identifies Pathways Associated with Hepatocellular Carcinoma from Peripheral Blood Samples
inferred← citeshttps://doi.org/10.3390/metabo10020051openalex-snapshot
Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine
inferred← citeshttps://doi.org/10.3390/metabo13030444openalex-snapshot
Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification
inferred← citeshttps://doi.org/10.3390/metabo13101047openalex-snapshot
Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies
inferred← citeshttps://doi.org/10.3390/metabo13111112openalex-snapshot
Molecular and Metabolic Phenotyping of Hepatocellular Carcinoma for Biomarker Discovery: A Meta-Analysis
inferred← citeshttps://doi.org/10.3390/metabo15080504openalex-snapshot
Metabolomic Profiling of Hepatitis B-Associated Liver Disease Progression: Chronic Hepatitis B, Cirrhosis, and Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.4251/wjgo.v13.i11.1847openalex-snapshot
Hepatocellular carcinoma biomarkers, an imminent need
inferred← citeshttps://doi.org/10.4251/wjgo.v13.i12.2219openalex-snapshot
Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota
inferred← citeshttps://doi.org/10.4251/wjgo.v13.i4.197openalex-snapshot
Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
inferred← citeshttps://doi.org/10.4251/wjgo.v13.i5.351openalex-snapshot
Biomarkers for hepatocellular carcinoma based on body fluids and feces
inferred← citeshttps://doi.org/10.5009/gnl250187openalex-snapshot
Precision Strategy for Hepatocellular Carcinoma Surveillance after Hepatitis C Cure: Debates across Guidelines
inferred← citeshttps://doi.org/10.6084/m9.figshare.24181101openalex-snapshot
Additional file 1 of Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.7759/cureus.71968openalex-snapshot
Altered Metabolites in Hepatocellular Carcinoma (HCC) Paving the Road for Metabolomics Signature and Biomarkers for Early Diagnosis of HCC
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.